NasdaqCM - Delayed Quote USD
Citius Pharmaceuticals, Inc. (CTXR)
0.8746
-0.0454
(-4.93%)
At close: June 13 at 4:00:02 PM EDT
0.8780
+0.00
+(0.39%)
After hours: June 13 at 7:40:51 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 453.91k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
HOLUKA EUGENE MYRON Director | Conversion of Exercise of derivative security at price 0.02 per share. | Direct | 36 | Mar 13, 2024 |
WEBB CAROL A Director | Conversion of Exercise of derivative security at price 0.02 per share. | Direct | 181 | Mar 4, 2024 |
Related Tickers
EVGN Evogene Ltd.
1.3800
-9.21%
NCNA NuCana plc
0.1149
-24.41%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
KZIA Kazia Therapeutics Limited
9.30
-5.01%
SNPX Synaptogenix, Inc.
3.7100
-23.66%
UNCY Unicycive Therapeutics, Inc.
0.6814
+6.82%
PLRZ Polyrizon Ltd.
0.8350
-21.96%
VXRT Vaxart, Inc.
0.7020
+30.73%
CARM Carisma Therapeutics, Inc.
0.4516
-17.62%
PHAT Phathom Pharmaceuticals, Inc.
10.64
+6.08%